We don’t fund ideas—we fund answers.
At WARPNINE, we back clinical trials that give people with cancer more than hope—they give them options.
We work where the need is urgent, where research is underfunded, and where traditional systems are too slow to respond. Every trial we support is designed to deliver real outcomes: preserving quality of life, opening the door to curative treatments, and pushing cancer care beyond the status quo.
With your support, we can move faster. Below are the patient-focused trials we’re preparing to launch—each one a powerful opportunity to change what’s possible, now.
Watch Joseph's Story
With your support.
PECAN
Trial
Preventing chemotherapy-induced nerve damage
A 40-patient pilot study testing whether PEA, a naturally occurring compound, can prevent one of chemotherapy’s most disabling side effects: peripheral neuropathy.
→ Funding Required: $186,000
→ Ready to launch upon funding
→ Target impact: Protect nerve health, preserve mobility, improve treatment tolerance
PREDICT Trial
Improving nausea control without long-term harm
This study replaces dexamethasone—a common but toxic anti-nausea steroid—with a safer dual-steroid protocol. It’s a smarter, gentler approach for patients facing extended chemotherapy.
→ Funding Required: $112,000
→ Ethics approved; clinical team ready
→ Target impact: Maintain nausea control while reducing mood, sleep, and metabolic complications
iGOLSTA
Trial
Redefining treatment for oesophageal and gastric cancers
A bold, multi-arm trial combining immunotherapy, tumour-penetrating peptides, and modified chemotherapy for patients with some of the poorest survival rates in Australia.
→ Finalist for Best New Concept at the 2023 AGITG Annual Scientific Meeting
→ Seeking support for biomarker research, regional patient access, and translational sub-studies
→ Approx. per-patient cost: $78,000
Trials Ready to Launch
Why Your Support Matters
These cancers—pancreatic, gastrointestinal, and rare—are among the most lethal and least funded. But with your support, we’re changing that.
Our model is different. We don’t fund theory—we fast-track patient-focused trials that are ready to make a real-world impact.
✅ Registered charity and clinical trial sponsor
We’re lean, independent, and built for action—not admin.
🕒 From lab to life faster
We fund trials designed for rapid translation into real treatment options.
🌏 Equity in access
Public or private, city or regional—we support patients wherever they are.
📈 Transparent impact tracking
We track outcomes, not outputs—so you’ll always know what your support is achieving.
Let's Talk Impact
Your giving can do more than make a difference—it can change what’s possible.
Your Support Has Immediate Impact
A gift of $10,000 can help fund the cost of a patient’s participation in a smaller trial like PECAN or PREDICT.
Larger contributions can unlock entire trial arms, site activations, or co-fund complex studies like iGOLSTA.
No matter the size, your support fuels progress that patients can feel—right now.
Let’s discuss how your giving could shape the future of cancer care.
Contact: Meg Croucher, CEO – meg@warpnine.org.au